title: Psoriasis and psoriatic arthritis induced by nivolumab in a patient with advanced lung cancer.
authors.affiliation: Department of Dermatology.
authors.forename: Sarah
authors.initials: S
authors.lastname: Law-Ping-Man
authors.affiliation: Department of Rheumatology.
authors.forename: Antoine
authors.initials: A
authors.lastname: Martin
authors.affiliation: Department of Pulmonary Medicine, Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Briens
authors.affiliation: Armor Pathology Laboratory, Plérin, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Tisseau
authors.affiliation: Department of Dermatology gilles.safa@ch-stbrieuc.fr.
authors.forename: Gilles
authors.initials: G
authors.lastname: Safa
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000139:chemically induced* / Q000175:diagnosis; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D009367:Neoplasm Staging; D000077594:Nivolumab; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab